Clinical Practice Guideline for Clinical Application of Biosimilars

Title: Clinical Practice Guideline for Clinical Application of Biosimilars
Edition: Original
Classification: Standard guideline
Field: Comprehensive guideline
Countries and regions: China
Guidelines users:
Evidence classification method:
Development unit: Peking University Third Hospital
Registration time: 2020-11-04
Registration number: IPGRP-2020CN172
Purpose of the guideline: